A5075734373- Neurological Disorders and Treatments
- Neurological Disease Mechanisms and Treatments
- Microscopic Colitis
- Biochemical effects in animals
- Helicobacter pylori-related gastroenterology studies
- Acute Ischemic Stroke Management
- Clostridium difficile and Clostridium perfringens research
City Clinical Hospital
2018-2023
Chronic cerebral ischemia (CCI) is a common syndrome that, in the absence of adequate therapy, characterized by progressive course, an increase cognitive, emotional, motor and other disorders, eventually leading to persistent disability patient. In treatment patients with CCI, use drugs multimodal neuroprotective effect indicated. The results analysis series clinical trials Mexidol FORTE CCI are presented. effects relation asthenic, vegetative manifestations considered. It concluded that it...
The objective of the study was to evaluate prevalence Clostridium difficile-associated diarrhoea (CDAD) among hospitalised patients with antibiotic-associated (AAD) in general and by specific types medical care hospital units. A prospective, cross-sectional, non-interventional, multicentre study. main inclusion criteria were: patient age ≥ 18 years, stay at least 48 h, current antibiotic therapy or within previous 30 days, loose stools (Bristol stool 5–7 frequency 3 ≤ 24 consecutive hours...
--
This study is devoted to systemic enzyme therapy (wobenzym and phlogenzym) influence on hemostasis, hemorheology, clinical course of disease inpatients (n=54) with Functional Class II-III effort angina, receiving complex therapy. Systemic improved blood rheology due decreased red white cell aggregation, increased elasticity membrane; optimized fibrinolysis hemocoagulation systems' status; angina quality life. Including wobenzym phlogenzym into ofFC patients clinically rational, effective, safe.